Why Teladoc Health, Inc. (TDOC) Crashed on Thursday

We recently compiled a list of the 10 Stocks Mirror Wall Street Downturn. In this article, we are going to take a look at where Teladoc Health, Inc. (NYSE:TDOC) stands against the other stocks.

Shares on Wall Street traded lower on Thursday, as investors moved to unload positions to mitigate risks from uncertainties brought about by key economic factors such as President Donald Trump’s continued tariff threats and policy shifts.

The Dow Jones dived by 1.01 percent, the S&P 500 declined 0.43 percent, while the tech-heavy Nasdaq lost 0.47 percent.

Ten companies also mirrored a broader market downturn, finishing the trading session in the red territory amid a flurry of catalysts dampening investor sentiment.

To come up with Thursday’s worst performers, we considered only the stocks with $2 billion in market capitalization and $5 million in daily trading volume.

A doctor wearing a face mask and lab coat providing remote medical advice via video chat.

Teladoc Health, Inc. (NYSE:TDOC)

Shares of Teladoc Health, Inc. (NYSE:TDOC) fell 7.84 percent on Thursday to finish at $12.69 apiece as investor sentiment was dampened by news that it is being investigated by a shareholder law firm for potential securities law violations.

According to Block & Leviton LLP, it is underway with the investigation of Teladoc Health, Inc. (NYSE:TDOC) following a report from Blue Orca Capital alleging the company has misled investors about its BetterHelp platform and financial reporting.

The report claimed that the platform used AI-generated responses in place of licensed therapists, without any disclosures to investors and patients.

The report also claimed that Teladoc Health, Inc. (NYSE:TDOC) inflated profitability by shifting research and development expenses.

In other news, TDOC recently announced the acquisition of Catapult Health, a national preventive healthcare practice offering preventive checkups through VirtualCheckups, for $65 million.

Teladoc Health, Inc. (NYSE:TDOC) said the acquisition was in line with its efforts to improve early detection of health conditions, expand into at-home diagnostic testing, and deliver better health outcomes in care management that would complement its industry-leading suite of integrated solutions.

Overall TDOC ranks 9th on our list of Thursday’s top losers. While we acknowledge the potential of TDOC as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TDOC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure: None. This article is originally published at Insider Monkey.